Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke

Cell-based therapies are emerging as new promising treatments in stroke. However, their functional mechanism and therapeutic potential during early infarct maturation has so far received little attention. Here, we asked if cell-based delivery of the interleukin-1 receptor antagonist (IL-1Ra), a know...

Descripción completa

Detalles Bibliográficos
Autores principales: Clausen, Bettina Hjelm, Lambertsen, Kate Lykke, Dagnæs-Hansen, Frederik, Babcock, Alicia Anne, von Linstow, Christian Ulrich, Meldgaard, Michael, Kristensen, Bjarne Winther, Deierborg, Tomas, Finsen, Bente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835531/
https://www.ncbi.nlm.nih.gov/pubmed/26860727
http://dx.doi.org/10.1007/s00401-016-1541-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835531/
https://www.ncbi.nlm.nih.gov/pubmed/26860727
http://dx.doi.org/10.1007/s00401-016-1541-5

Ejemplares similares